IBDEI069 ; ; 09-FEB-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8358,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,8358,2)
 ;;=DM Type I, No Retinopathy^33586
 ;;^UTILITY(U,$J,358.3,8359,0)
 ;;=250.50^^53^573^25
 ;;^UTILITY(U,$J,358.3,8359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8359,1,3,0)
 ;;=3^Csme In DM Type II
 ;;^UTILITY(U,$J,358.3,8359,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,8359,2)
 ;;=CSME in DM type II^267839^362.83
 ;;^UTILITY(U,$J,358.3,8360,0)
 ;;=250.51^^53^573^27
 ;;^UTILITY(U,$J,358.3,8360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8360,1,3,0)
 ;;=3^DM Type I w/ Ophtharlmic Manifestation
 ;;^UTILITY(U,$J,358.3,8360,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,8360,2)
 ;;=CSME in DM Type I^267840^362.83
 ;;^UTILITY(U,$J,358.3,8361,0)
 ;;=362.01^^53^573^32
 ;;^UTILITY(U,$J,358.3,8361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8361,1,3,0)
 ;;=3^Diabetic Retinopathy Nos
 ;;^UTILITY(U,$J,358.3,8361,1,4,0)
 ;;=4^362.01
 ;;^UTILITY(U,$J,358.3,8361,2)
 ;;=^12257
 ;;^UTILITY(U,$J,358.3,8362,0)
 ;;=362.02^^53^573^72
 ;;^UTILITY(U,$J,358.3,8362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8362,1,3,0)
 ;;=3^Prolif Diab Retinopathy
 ;;^UTILITY(U,$J,358.3,8362,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,8362,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,8363,0)
 ;;=362.03^^53^573^64
 ;;^UTILITY(U,$J,358.3,8363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8363,1,3,0)
 ;;=3^Nonprolf Db Retnoph Nos
 ;;^UTILITY(U,$J,358.3,8363,1,4,0)
 ;;=4^362.03
 ;;^UTILITY(U,$J,358.3,8363,2)
 ;;=^332786
 ;;^UTILITY(U,$J,358.3,8364,0)
 ;;=362.04^^53^573^61
 ;;^UTILITY(U,$J,358.3,8364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8364,1,3,0)
 ;;=3^Mild Nonprolf Db Retnoph
 ;;^UTILITY(U,$J,358.3,8364,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,8364,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,8365,0)
 ;;=362.05^^53^573^62
 ;;^UTILITY(U,$J,358.3,8365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8365,1,3,0)
 ;;=3^Mod Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,8365,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,8365,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,8366,0)
 ;;=362.06^^53^573^98
 ;;^UTILITY(U,$J,358.3,8366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8366,1,3,0)
 ;;=3^Sev Nonprolf Db Retinoph
 ;;^UTILITY(U,$J,358.3,8366,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,8366,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,8367,0)
 ;;=379.27^^53^573^103
 ;;^UTILITY(U,$J,358.3,8367,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8367,1,3,0)
 ;;=3^Vitreomacular Adhesion
 ;;^UTILITY(U,$J,358.3,8367,1,4,0)
 ;;=4^379.27
 ;;^UTILITY(U,$J,358.3,8367,2)
 ;;=^340517
 ;;^UTILITY(U,$J,358.3,8368,0)
 ;;=115.02^^53^573^44
 ;;^UTILITY(U,$J,358.3,8368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8368,1,3,0)
 ;;=3^Histoplasma Capsulatum Retinitis
 ;;^UTILITY(U,$J,358.3,8368,1,4,0)
 ;;=4^115.02
 ;;^UTILITY(U,$J,358.3,8368,2)
 ;;=^266890
 ;;^UTILITY(U,$J,358.3,8369,0)
 ;;=190.5^^53^573^58
 ;;^UTILITY(U,$J,358.3,8369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8369,1,3,0)
 ;;=3^Malig Retina
 ;;^UTILITY(U,$J,358.3,8369,1,4,0)
 ;;=4^190.5
 ;;^UTILITY(U,$J,358.3,8369,2)
 ;;=^73530
 ;;^UTILITY(U,$J,358.3,8370,0)
 ;;=198.4^^53^573^59
 ;;^UTILITY(U,$J,358.3,8370,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8370,1,3,0)
 ;;=3^Malig Secondary Choroid
 ;;^UTILITY(U,$J,358.3,8370,1,4,0)
 ;;=4^198.4
 ;;^UTILITY(U,$J,358.3,8370,2)
 ;;=^267335
 ;;^UTILITY(U,$J,358.3,8371,0)
 ;;=200.00^^53^573^81
 ;;^UTILITY(U,$J,358.3,8371,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8371,1,3,0)
 ;;=3^Reticulosarcoma,Unspec
 ;;^UTILITY(U,$J,358.3,8371,1,4,0)
 ;;=4^200.00
 ;;^UTILITY(U,$J,358.3,8371,2)
 ;;=^72635
 ;;^UTILITY(U,$J,358.3,8372,0)
 ;;=228.03^^53^573^38
 ;;^UTILITY(U,$J,358.3,8372,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8372,1,3,0)
 ;;=3^Hemangioma Retina
 ;;^UTILITY(U,$J,358.3,8372,1,4,0)
 ;;=4^228.03
 ;;^UTILITY(U,$J,358.3,8372,2)
 ;;=^267700
 ;;^UTILITY(U,$J,358.3,8373,0)
 ;;=228.09^^53^573^39
 ;;^UTILITY(U,$J,358.3,8373,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8373,1,3,0)
 ;;=3^Hemangioma,Oth Sites
 ;;^UTILITY(U,$J,358.3,8373,1,4,0)
 ;;=4^228.09
 ;;^UTILITY(U,$J,358.3,8373,2)
 ;;=^55270
 ;;^UTILITY(U,$J,358.3,8374,0)
 ;;=360.00^^53^573^73
 ;;^UTILITY(U,$J,358.3,8374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8374,1,3,0)
 ;;=3^Purulent Endophthalmitis,Unspec
 ;;^UTILITY(U,$J,358.3,8374,1,4,0)
 ;;=4^360.00
 ;;^UTILITY(U,$J,358.3,8374,2)
 ;;=^40605
 ;;^UTILITY(U,$J,358.3,8375,0)
 ;;=360.03^^53^573^21
 ;;^UTILITY(U,$J,358.3,8375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8375,1,3,0)
 ;;=3^Chronic Endophthalmitis
 ;;^UTILITY(U,$J,358.3,8375,1,4,0)
 ;;=4^360.03
 ;;^UTILITY(U,$J,358.3,8375,2)
 ;;=^268547
 ;;^UTILITY(U,$J,358.3,8376,0)
 ;;=361.02^^53^573^76
 ;;^UTILITY(U,$J,358.3,8376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8376,1,3,0)
 ;;=3^Recent RD w/ Multiple Defects
 ;;^UTILITY(U,$J,358.3,8376,1,4,0)
 ;;=4^361.02
 ;;^UTILITY(U,$J,358.3,8376,2)
 ;;=^268587
 ;;^UTILITY(U,$J,358.3,8377,0)
 ;;=361.03^^53^573^75
 ;;^UTILITY(U,$J,358.3,8377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8377,1,3,0)
 ;;=3^Recent RD w/ Giant Tear
 ;;^UTILITY(U,$J,358.3,8377,1,4,0)
 ;;=4^361.03
 ;;^UTILITY(U,$J,358.3,8377,2)
 ;;=^268588
 ;;^UTILITY(U,$J,358.3,8378,0)
 ;;=361.04^^53^573^79
 ;;^UTILITY(U,$J,358.3,8378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8378,1,3,0)
 ;;=3^Ret Det,Partial w/ Dialysis
 ;;^UTILITY(U,$J,358.3,8378,1,4,0)
 ;;=4^361.04
 ;;^UTILITY(U,$J,358.3,8378,2)
 ;;=^268589
 ;;^UTILITY(U,$J,358.3,8379,0)
 ;;=361.12^^53^573^8
 ;;^UTILITY(U,$J,358.3,8379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8379,1,3,0)
 ;;=3^Bullous Retinoschisis
 ;;^UTILITY(U,$J,358.3,8379,1,4,0)
 ;;=4^361.12
 ;;^UTILITY(U,$J,358.3,8379,2)
 ;;=^268596
 ;;^UTILITY(U,$J,358.3,8380,0)
 ;;=361.2^^53^573^102
 ;;^UTILITY(U,$J,358.3,8380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8380,1,3,0)
 ;;=3^Uveal Effusion/SRD
 ;;^UTILITY(U,$J,358.3,8380,1,4,0)
 ;;=4^361.2
 ;;^UTILITY(U,$J,358.3,8380,2)
 ;;=^268601
 ;;^UTILITY(U,$J,358.3,8381,0)
 ;;=361.9^^53^573^83
 ;;^UTILITY(U,$J,358.3,8381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8381,1,3,0)
 ;;=3^Retinal Detachment NOS
 ;;^UTILITY(U,$J,358.3,8381,1,4,0)
 ;;=4^361.9
 ;;^UTILITY(U,$J,358.3,8381,2)
 ;;=^105529
 ;;^UTILITY(U,$J,358.3,8382,0)
 ;;=362.10^^53^573^95
 ;;^UTILITY(U,$J,358.3,8382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8382,1,3,0)
 ;;=3^Rubella Retinopathy
 ;;^UTILITY(U,$J,358.3,8382,1,4,0)
 ;;=4^362.10
 ;;^UTILITY(U,$J,358.3,8382,2)
 ;;=^12267
 ;;^UTILITY(U,$J,358.3,8383,0)
 ;;=362.12^^53^573^22
 ;;^UTILITY(U,$J,358.3,8383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8383,1,3,0)
 ;;=3^Coats' Disease
 ;;^UTILITY(U,$J,358.3,8383,1,4,0)
 ;;=4^362.12
 ;;^UTILITY(U,$J,358.3,8383,2)
 ;;=^268612
 ;;^UTILITY(U,$J,358.3,8384,0)
 ;;=362.13^^53^573^88
 ;;^UTILITY(U,$J,358.3,8384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8384,1,3,0)
 ;;=3^Retinal Vascular Changes
 ;;^UTILITY(U,$J,358.3,8384,1,4,0)
 ;;=4^362.13
 ;;^UTILITY(U,$J,358.3,8384,2)
 ;;=^268614
 ;;^UTILITY(U,$J,358.3,8385,0)
 ;;=362.14^^53^573^82
 ;;^UTILITY(U,$J,358.3,8385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8385,1,3,0)
 ;;=3^Retina Microaneurysm NOS
 ;;^UTILITY(U,$J,358.3,8385,1,4,0)
 ;;=4^362.14
 ;;^UTILITY(U,$J,358.3,8385,2)
 ;;=^268615
 ;;^UTILITY(U,$J,358.3,8386,0)
 ;;=362.17^^53^573^52
 ;;^UTILITY(U,$J,358.3,8386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8386,1,3,0)
 ;;=3^Macroaneurysm
 ;;^UTILITY(U,$J,358.3,8386,1,4,0)
 ;;=4^362.17
 ;;^UTILITY(U,$J,358.3,8386,2)
 ;;=^268617
 ;;^UTILITY(U,$J,358.3,8387,0)
 ;;=362.21^^53^573^71
 ;;^UTILITY(U,$J,358.3,8387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8387,1,3,0)
 ;;=3^Prematurity-ROP
 ;;^UTILITY(U,$J,358.3,8387,1,4,0)
 ;;=4^362.21
 ;;^UTILITY(U,$J,358.3,8387,2)
 ;;=^105733
 ;;^UTILITY(U,$J,358.3,8388,0)
 ;;=362.29^^53^573^63
 ;;^UTILITY(U,$J,358.3,8388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8388,1,3,0)
 ;;=3^Nondiabetic PR
 ;;^UTILITY(U,$J,358.3,8388,1,4,0)
 ;;=4^362.29
 ;;^UTILITY(U,$J,358.3,8388,2)
 ;;=^268619
 ;;^UTILITY(U,$J,358.3,8389,0)
 ;;=362.30^^53^573^40
 ;;^UTILITY(U,$J,358.3,8389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8389,1,3,0)
 ;;=3^Hemiretinal Vein Occlusion
 ;;^UTILITY(U,$J,358.3,8389,1,4,0)
 ;;=4^362.30
 ;;^UTILITY(U,$J,358.3,8389,2)
 ;;=^105640
 ;;^UTILITY(U,$J,358.3,8390,0)
 ;;=362.37^^53^573^9
 ;;^UTILITY(U,$J,358.3,8390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8390,1,3,0)
 ;;=3^CRVO-Partial
 ;;^UTILITY(U,$J,358.3,8390,1,4,0)
 ;;=4^362.37
 ;;^UTILITY(U,$J,358.3,8390,2)
 ;;=^268627
 ;;^UTILITY(U,$J,358.3,8391,0)
 ;;=362.50^^53^573^51
 ;;^UTILITY(U,$J,358.3,8391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8391,1,3,0)
 ;;=3^Mac Degen,Senile/Atrophy
 ;;^UTILITY(U,$J,358.3,8391,1,4,0)
 ;;=4^362.50
 ;;^UTILITY(U,$J,358.3,8391,2)
 ;;=^73072
 ;;^UTILITY(U,$J,358.3,8392,0)
 ;;=362.70^^53^573^28
 ;;^UTILITY(U,$J,358.3,8392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8392,1,3,0)
 ;;=3^Degen/Hered Disorder
 ;;^UTILITY(U,$J,358.3,8392,1,4,0)
 ;;=4^362.70
 ;;^UTILITY(U,$J,358.3,8392,2)
 ;;=^268650
 ;;^UTILITY(U,$J,358.3,8393,0)
 ;;=362.74^^53^573^91
 ;;^UTILITY(U,$J,358.3,8393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8393,1,3,0)
 ;;=3^Retinitis Pigmentosa
 ;;^UTILITY(U,$J,358.3,8393,1,4,0)
 ;;=4^362.74
 ;;^UTILITY(U,$J,358.3,8393,2)
 ;;=^105693
 ;;^UTILITY(U,$J,358.3,8394,0)
 ;;=362.75^^53^573^50
 ;;^UTILITY(U,$J,358.3,8394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8394,1,3,0)
 ;;=3^Mac Degen,Juvenile
 ;;^UTILITY(U,$J,358.3,8394,1,4,0)
 ;;=4^362.75
 ;;^UTILITY(U,$J,358.3,8394,2)
 ;;=^268656
 ;;^UTILITY(U,$J,358.3,8395,0)
 ;;=362.76^^53^573^74
 ;;^UTILITY(U,$J,358.3,8395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8395,1,3,0)
 ;;=3^RPE Hypertrophy
 ;;^UTILITY(U,$J,358.3,8395,1,4,0)
 ;;=4^362.76
 ;;^UTILITY(U,$J,358.3,8395,2)
 ;;=^268657
 ;;^UTILITY(U,$J,358.3,8396,0)
 ;;=362.82^^53^573^85
 ;;^UTILITY(U,$J,358.3,8396,1,0)
 ;;=^358.31IA^4^2
